Lloyd Mitchell Segal

CIK 1477123 · PRESIDENT AND CEO · last filed 2026-01-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$430.5K

Companies

3

Total Filings

36

Lifetime Open-Market Net

-$1.89M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKTS Director 19,631 $21.93 $430.5K $0 1 2026-01-12
Repare Therapeutics Inc. (RPTX) Delisted PRESIDENT AND CEO 231,952 $2.65 $614.7K -$1.89M 17 2025-03-14
Bausch Health Companies Inc. (BVF) Delisted Director $0 4 2010-07-07

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-12-23 Grant (A) $0
2010-10-06 Grant (A) $0
2010-07-07 Bausch Health Companies Inc. (BVF) Delisted Grant (A) $0 EDGAR
2010-05-25 Bausch Health Companies Inc. (BVF) Delisted Grant (A) $0 EDGAR
2010-04-07 Bausch Health Companies Inc. (BVF) Delisted Grant (A) $0 EDGAR
2010-01-06 Bausch Health Companies Inc. (BVF) Delisted Grant (A) $0 EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.